Temporal changes in cardiovascular autonomic regulation in type II diabetic patients: Association with coronary risk variables and progression of coronary artery disease

Annals of Medicine

Volumn 35, Issue 3, 2003, Pages 216-223

  Jokinen, Vesa ^a   Ukkola, Olavi ^a   Airaksinen, K E Juhani ^a   Koistinen, Juhani M ^a   Ikäheimo, Markku J ^a   Kesäniemi, Y Antero ^a   Huikuri, Heikki V ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Autonomic nervous system; Coronary artery disease; Diabetes; Heart rate

Indexed keywords

CHOLESTEROL; FENOFIBRATE; GLUCOSE; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FRACTAL ANALYSIS; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROCETOFEN; RISK FACTORS; TIME FACTORS;

EID: 0038121950     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310008279     Document Type: Article

References (35)

1. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Meg 1993; 10: 664-71.
2. Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MI. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 1996; 45: 308-15.
3. Huikuri HV, Ylitalo A, Pikkujämsä SM, Ikäheimo MJ, Airaksinen KE, Rantala AO and et al. Heart rate variability in systemic hypertension. Am. J Cardiol 1996; 77: 1073-7.
4. Pikkujämsä SM, Huikuri HV, Airaksinen KE, Rantala AO, Kauma H, Lilja M, et al. Heart rate variability and baroreflex sensitivity in hypertensive subiects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 1998; 11: 523-31.
5. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999; 84: 687-91.
6. Burger AJ, Charlamb M, Sherman HB. Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol 1999; 71: 41-8.
7. Koskinen P, Kupari M, Virolainen J, Stjernvall J, Jolkkonen J, Tuomilehto J, et al. Heart rate and blood pressure variability and baroreflex sensitivity in hypercholesterolaemia. Clin Physiol 1995; 13: 483-9.
8. Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001; 357: 905-10.
9. Steiner G. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group. Diabetologia 1996; 39: 1655-61.
10. Friedewald WT, Levy RI, Fredrickson DS.. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-02.
11. McGuinness C, Seccombe DW, Frohlich JJ, Ehnholm C, Sundvall J, Steiner G. Laboratory standardization of a large international clinical trial: the DAIS experience. Clin Biochem 2000; 33: 15-24.
12. McLaughlin PR, Gladstone P. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary anglographic analysis of coronary artery atherosclerosis. Catheter Cardiovasc Diagn 1998; 44: 249-56.
13. Huikuri HV, Niemelä MJ, Ojala S, Rantala A, Ikäheimo MJ, Airaksinen KE. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and upright posture. Circulation 1994; 90: 121-6.
14. Bigger JT, Jr, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P, Cohen RJ. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 1996; 93: 2142-51.
15. Huikuri HV, Mäkikallio TH, Airaksinen KE, Seppänen T, Puukka P, Räihä IJ, et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 1998; 97: 2031-6.
16. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-81.
17. Makikallio TH, Seppänen T, Airaksinen KE, Koistinen J, Tulppo MP, Peng CK, et al. Dynamic analysis of heart rate may predict subsequent ventricular tachycardia after myocardial infarction. Am J Cardiol 1997; 80: 779-83.
18. Jokinen V, Syvänne M, Mäkikallio TH, Airaksinen KEJ, Huikuri HV. Temporal Age-Related Changes in Spectral, Fractal and Complexity characteristics of Heart Rate Variability. Clinical Physiology 2001; 21: 273-81.
19. Mäkikallio TH, Huikuri HV, Hintze U, Videbaek J, Mitrani RD, Castellanos A, et al. Fractal analysis and time-and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001; 87: 178-82.
20. Huikuri HV, Mäkikallio TH, Peng CK, Goldberger AL, Hintze U, Moiler M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction [see comments]. Circulation 2000; 101: 47-53.
21. Mäkikallio TH, Koistinen J, Jordaens L, Tulppo MP, Wood N, Golosarsky B, et al. Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol 1999; 83: 880-4.
22. Tulppo MP, Mäkikallio TH, Seppänen T, Shoemaker K, Tutungi E, Hughson RL, et al. Effects of pharmacological adrenergic and vagal modulation on fractal heart rate dynamics. Clin Physiol 2001; 21: 515-23.
23. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Länsimies EA, Uusitupa MI, et al. Power spectral analysis of heart rate variability during hyperinsulinemia in non-diabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48: 1295-9.
24. Stein PK, Domitrovich PP, Kleiger RE, Schechtman KB, Rottman JN. Clinical and demographic determinants of heart rate variability in patients post rnyocardial infarction: insights from the cardiac arrhythmia suppression trial (CAST). Clin Cardiol 2000; 23: 187-94.
25. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
26. Huikuri HV, Jokinen V, Syvänne M, Nieminen MS, Airaksinen KE, Ikäheimo MJ, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vase Biol 1999; 19: 1979-85.
27. Yu S-M, Tsai S-Y, Guh J-H, Ko F-N, Teng C-M, Ou J-T. Mechanisms of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation 1996; 94: 547-54.
28. Dzau vJ, Sarbs FM. Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol 1987; 10(suppl 9): S2-6.
29. Scwartz CJ, Mitchell JRA. Observations on localization of arterial plaques. Circ Res 1972; 11: 63-73.
30. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature 1969; 223: 1159-60.
31. Sprague EA, Steinbach BL, Nerem RM, Schwartz CJ. Influence of a laminar steady-state fluid-imposed wall shear stress on the binding, internalization, and degradation of low-density lipoproteins by cultured arterial endothelium. Circulation 1987; 76: 648-56.
32. Monahan KD, Tanaka H, Dinenno FA, Seals DR. Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensitivity. Circulation 2001; 104: 1627-32.
33. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024-8.
34. Simula S, Vanninen E, Vätanen L, Kareinen A, Lehto S, Pajunen P, et al. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease. J Nucl Med 2002; 43: 1-7.
35. Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care 1996; 19: 1083-90.